Survival analysis conducted in the GEPIA database indicated that elevated levels of CENPB mRNA were associated with unfavorable OS and RFS outcomes among HCC patients (Figure 1G, 1H). This evidence concerns the gene CENPB and hepatocellular carcinoma.